Stockreport

Upstream Bio to Participate in Upcoming November Investor Conferences

Upstream Bio, Inc.  (UPB) 
PDF WALTHAM, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an i [Read more]